EGFR-Targeted Therapy Alters the Tumor Microenvironment In EGFR-Driven Lung Tumors: Rationale for Combination Therapies

被引：0
|
作者：
Jia, Y. [1 ]
Jiang, T. [1 ]
Li, X. [1 ]
Zhao, C. [1 ]
Zhou, C. [1 ]
Zhao, S. [1 ]
机构：
[1] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Med Oncol, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
lung cancer; EGFR-TKI; tumor microenvironment;
D O I：
10.1016/j.jtho.2018.08.554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA27.10
引用
收藏
页码：S457 / S457
页数：1
相关论文
共 50 条
  • [41] EGFR-TARGETED SELECTIVE GENE THERAPY FOR NON-SMALL CELL LUNG CANCER (NSCLC)
    Yamaguchi, Miki
    Nakamura, Kiminori
    Sakuragi, Naoya
    Kato, Kazunori
    Hamada, Hirofumi
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1056 - 1057
  • [42] Integrated genomic analysis for revealing broad remodeling of EGFR-targeted therapy resistant lung cancers
    Giannikopoulos, Petros
    St John, John A.
    Parker, Joel S.
    Westesson, Oscar
    Hahner, Nicholas J.
    Karachaliou, Niki
    Costa, Carlota
    Caulin, Aleah F.
    Lozano, Maria D.
    Perez-Gracia, Jose Luis
    Fontecedro, Alessandra Curioni
    Jantus-Lewintre, Eloisa
    Vergnenegre, Alain
    Gervais, Radj
    Bordoni, Rodolfo
    Stahel, Rolf A.
    Zorrilla, Andres Felipe Cardona
    Weissman, Jonathan S.
    Polkinghorn, William Reilly
    Bivona, Trever Grant
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [43] In vitro responses to EGFR-targeted therapy with the anti-EGFR antibody ICR62 and/or gefitinib in colorectal tumor cells.
    Cunningham, MP
    Marks, C
    Green, M
    Thomas, H
    Fan, Z
    Modjtahedi, H
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9045S - 9045S
  • [44] Exploratory Evaluation of EGFR-Targeted Anti-Tumor Drugs for Lung Cancer Based on Lung-on-a-Chip
    Tan, Jianfeng
    Sun, Xindi
    Zhang, Jianhua
    Li, Huili
    Kuang, Jun
    Xu, Lulu
    Gao, Xinghua
    Zhou, Chengbin
    BIOSENSORS-BASEL, 2022, 12 (08):
  • [45] Impact of EGFR-TKIs combined with PD-L1 antibody on the lung tissue of EGFR-driven tumor-bearing mice
    Jia, Yijun
    Zhao, Sha
    Jiang, Tao
    Li, Xuefei
    Zhao, Chao
    Liu, Yiwei
    Han, Ruoshuang
    Qiao, Meng
    Liu, Sangtian
    Su, Chunxia
    Ren, Shengxiang
    Zhou, Caicun
    LUNG CANCER, 2019, 137 : 85 - 93
  • [46] Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosis
    Zhang, Shuo
    Chen, Zhen
    Shi, Puyu
    Fan, Songqing
    He, Yong
    Wang, Qiming
    Li, Yixiang
    Ramalingam, Suresh S.
    Owonikoko, Taofeek K.
    Sun, Shi-Yong
    THERANOSTICS, 2021, 11 (08): : 3964 - 3980
  • [47] Reduced Risk of Incident Chronic Obstructive Pulmonary Disease Following EGFR-targeted Therapies in Patients With Lung Cancer
    Chan, S.
    Huang, P.
    Ma, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [48] Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation
    Chen, Nan
    Fang, Wenfeng
    Zhan, Jianhua
    Hong, Shaodong
    Tang, Yanna
    Kang, Shiyang
    Zhang, Yaxiong
    He, Xiaobo
    Zhou, Ting
    Qin, Tao
    Huang, Yan
    Yi, Xianping
    Zhang, Li
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (06) : 910 - 923
  • [49] KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies
    Maus, M. K. H.
    Grimminger, P. P.
    Mack, P. C.
    Astrow, S. H.
    Stephens, C.
    Zeger, G.
    Hsiang, J.
    Brabender, J.
    Friedrich, M.
    Alakus, H.
    Hoelscher, A. H.
    Lara, P.
    Danenberg, K. D.
    Lenz, H. J.
    Gandara, D. R.
    LUNG CANCER, 2014, 83 (02) : 163 - 167
  • [50] Therapeutic Efficacy and Safety Profile of EGFR-Targeted Oncolytic Ad Nanocomplex in Orthotopic Lung Tumor Model
    Yoon, A-Rum
    Kasala, Dayananda
    Li, Yan
    Hong, Jinwoo
    Lee, Wonsig
    Jung, Soo-Jung
    Yun, Chae-Ok
    MOLECULAR THERAPY, 2016, 24 : S46 - S46
12345